506687 — Transpek Industry Income Statement
0.000.00%
Last trade - 00:00
- IN₹9.83bn
- IN₹10.73bn
- IN₹5.80bn
- 80
- 36
- 51
- 59
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IAS | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 5,656 | 3,394 | 5,991 | 8,269 | 5,796 |
Cost of Revenue | |||||
Gross Profit | 2,588 | 1,464 | 2,383 | 3,368 | 2,922 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 4,723 | 3,203 | 5,270 | 7,029 | 5,349 |
Operating Profit | 933 | 191 | 721 | 1,240 | 447 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 935 | 255 | 842 | 1,128 | 555 |
Provision for Income Taxes | |||||
Net Income After Taxes | 729 | 233 | 654 | 835 | 386 |
Net Income Before Extraordinary Items | |||||
Net Income | 729 | 233 | 654 | 835 | 386 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 729 | 233 | 654 | 835 | 386 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 131 | 40 | 123 | 153 | 69 |
Dividends per Share |